Parkman Healthcare Partners LLC Kala Pharmaceuticals, Inc. Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$5.06 - $8.15 $751,070 - $1.21 Million	-148,433 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$6.24 - $9.58 $773,834 - $1.19 Million	-124,012 Reduced 45.52%	148,433 $1 Million
Q4 2020 Feb 12, 2021	SELL	$6.28 - $8.79 $236,178 - $330,574	-37,608 Reduced 12.13%	272,445 $1.85 Million
Q3 2020 Nov 13, 2020	BUY	$7.5 - $11.11 $262,897 - $389,438	35,053 Added 12.75%	310,053 $2.33 Million
Q2 2020 Aug 13, 2020	BUY	$8.33 - $13.79 $416,500 - $689,500	50,000 Added 22.22%	275,000 $2.89 Million

Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $861,750 - $1.98 Million	225,000 New	225,000 $1.98 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.